Blog ยท PsychMed Care

The PsychMed Care blog.

One article a week on a question patients are asking, answered from the published evidence and written in plain language. No miracle claims, no product promotion, and each article lists its sources.

PsychMed Care is the medication management practice of Solutions Psychiatry. Therapy, and therapy with medication together, are at psych.us, which keeps its own blog.

At-Home Brain Stimulation for Depression: What Was Approved

The sixth post: the Flow FL-100 at-home tDCS approval of December 8, 2025, the 174-person Empower trial results, the FDA own statement of moderate uncertainty, and the published critique of the approval.

A New ADHD Medicine: Centanafadine, Explained

The fifth post: centanafadine (Simtriyo), the new ADHD medicine approved in July 2026 and placed in Schedule III in October, what its four placebo-controlled trials found, and what they never tested.

Negative Symptoms of Schizophrenia: A New Option

The fourth post: negative symptoms of schizophrenia, the CONVOKE trial of a prescription app in 457 adults, the October 2026 FDA clearance, and how to read the headline percentage honestly.

CBT-I or Sleep Medicine: What the 2026 Guideline Says

The third post: the 2026 AASM guideline on combining CBT-I with insomnia medication, the ranking it produced, the six trials behind each comparison, and the exception it writes in for patients who value more sleep early.

Exercise and Depression: What Three Big Reviews Found

The second post: what the January 2026 Cochrane update, a 218-study BMJ analysis, and an umbrella review of 128,119 people found about exercise and depression, where they disagree, and what it means next to a medication plan.

GLP-1 Medicines and Mood: What the Research Shows

The first post: what the FDA review, an 86-trial meta-analysis, and a national cohort study found about GLP-1 medicines, depression, and suicidal thoughts, and what careful prescribers do with that.

Articles from the practice

Longer articles from this practice: how to taper off antidepressants safely, what to do when an antidepressant stops working, and the supplement shelf, graded by evidence.

How this blog works

A new article is published every Tuesday. Topics come from questions patients raise during treatment. Each article is checked against the published research before it is published.

“A medication that has done its job deserves a careful goodbye, planned like the treatment it was.”

Plan the goodbye: deprescribing, as a service